Lyudmila V Vinogradova Selected Research

Pilocarpine (Ocusert)

1/2019

Early endocannabinoid system activation attenuates behavioral impairments induced by initial impact but does not prevent epileptogenesis in lithium-pilocarpine status epilepticus model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lyudmila V Vinogradova Research Topics

Disease

6	Seizures (Absence Seizure) 08/2021 - 05/2007
3	Reflex Epilepsy (Photosensitive Epilepsy) 06/2015 - 08/2009
2	Brain Injuries (Brain Injury) 01/2020 - 10/2016
2	Epilepsy (Aura) 01/2019 - 06/2015
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019 - 10/2016
1	Anxiety Disorders (Anxiety Disorder) 01/2019
1	Hypersensitivity (Allergy) 08/2009

Drug/Important Bio-Agent (IBA)

4	EndocannabinoidsIBA 01/2019 - 10/2011
2	Explosive Agents (Explosives)IBA 08/2009 - 05/2007
1	CannabinoidsIBA 08/2021
1	LithiumIBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019
1	Cannabinoid Receptor AgonistsIBA 10/2016
1	RimonabantIBA 10/2011
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2011
1	Cannabinoid Receptor AntagonistsIBA 10/2011
1	Pharmaceutical PreparationsIBA 05/2007
1	Histamine (Histamine Dihydrochloride)FDA Link 05/2007

Therapy/Procedure

1	Neurosurgical Procedures 01/2020
1	Therapeutics 01/2019
1	Electrodes (Electrode) 10/2015
1	Intraperitoneal Injections 07/2008